Mahana Tinnitus Pilot
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing Mahana™ Tinnitus, a treatment for people who hear ringing in their ears. It involves about 250 adults who will use the treatment for several weeks. The goal is to see if it helps reduce their tinnitus symptoms.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What safety data exists for Mahana™ Tinnitus or similar treatments?
How does the Mahana™ Tinnitus treatment differ from other tinnitus treatments?
Mahana™ Tinnitus treatment is unique because it likely involves a mindfulness-based cognitive therapy (MBCT) approach, which focuses on reducing distress associated with tinnitus through mindfulness practices. This approach is different from traditional treatments that may rely on medications or sound therapy, as it aims to create neuroanatomical changes in the brain to alleviate symptoms.678910
What data supports the effectiveness of the treatment Mahana™ Tinnitus?
The research on sound therapy, such as the use of hearing aids with sound generators, shows that different types of noise can help relieve tinnitus symptoms. Additionally, low-powered ultrasound has been shown to improve tinnitus in some patients, suggesting that acoustic therapies can be effective in managing tinnitus.411121314
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to MHNA-003 (Mahana™ Tinnitus) and use it for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mahana™ Tinnitus
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mahana Therapeutics
Lead Sponsor